Table 2. . Longitudinal and transverse 50 kHz electrical impedance myography and Cole parameters of the left gastrocnemius.
Direction of measurement | Impedance parameter | PBS (n = 8) | ActRIIB-mFc dose mg/kg | ANOVA p-values | Post-hoc p-value | ||
---|---|---|---|---|---|---|---|
3.3 (n = 8) | 6.6 (n = 8) | 9.9 (n = 9) | |||||
Longitudinal | 50 kHz phase | 20.77 ± 0.525 | 21.04 ± 0.619 | 22.18 ± 0.601 | 22.63 ± 0.295 | 0.0451 | ns ns ns |
50 kHz reactance | 90.02 ± 3.49 | 80.66 ± 6.01 | 92.41 ± 4.72 | 89.00 ± 2.26 | ns | ns ns ns |
|
50 kHz resistance | 237.0 ± 4.98 | 207.7 ± 10.82 | 225.9 ± 7.29 | 213.4 ± 3.78 | 0.0317 | 0.0347 ns ns |
|
Transverse | 50 kHz phase | 22.61 ± 0.567 | 25.13 ± 0.453 | 25.34 ± 0.499 | 25.97 ± 0.507 | 0.0004 | 0.0088 0.0043 0.0003 |
50 kHz reactance | 126.6 ± 6.50 | 135.5 ± 7.51 | 155.6 ± 12.35 | 134.5 ± 4.99 | ns | ns ns ns |
|
50 kHz resistance | 304.6 ± 15.14 | 288.5 ± 13.81 | 332.8 ± 34.94 | 275.5 ± 5.73 | ns | ns ns ns |
|
Longitudinal | fc (kHz) | 37,705 ± 2475 | 31,873 ± 4760 | 30,127 ± 5150 | 31,482 ± 3219 | ns | ns ns ns |
R0/Rinf | 3.67 ± 0.206 | 3.68 ± 0.298 | 3.846 ± 0.229 | 4.34 ± 0.087 | ns | ns ns ns |
|
α | 0.7506 ± 0.0228 | 0.7093 ± 0.0116 | 0.7602 ± 0.0208 | 0.7075 ± 0.0082 | ns | ns ns ns |
|
Transverse | fc (kHz) | 58,423 ± 4021 | 38,875 ± 3182 | 40,097 ± 2940 | 36,487 ± 2125 | <0.0001 | 0.0007 0.0015 0.0001 |
R0/Rinf | 5.414 ± 0.344 | 6.065 ± 0.337 | 5.861 ± 0.346 | 6.385 ± 0.236 | ns | ns ns ns |
|
α | 0.7347 ± 0.0243 | 0.7131 ± 0.010 | 0.7481 ± 0.0254 | 0.7145 ± 0.0095 | ns | ns ns ns |
Phase shown in degrees, and reactance and resistance are shown in ohms. Data presented as mean ± standard error of the mean.
Post-hoc p-values are reported for the comparison between each individual ActRIIB-mFc dose versus the PBS control. None of the post-hoc p-values for the comparison between the various ActRIIB-mFc doses were significant.
ANOVA: analysis of variance; fc: Center frequency; ns: Not significant; PBS: Phosphate-buffered saline.